Patents by Inventor Theo D. Palmer

Theo D. Palmer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7998460
    Abstract: Methods are provided for protecting an individual from adverse long-term effects of neuroinflammation. Inflammatory blockade maintains neurogenesis capability after cranial irradiation by reducing the negative effects of activated microglia on neural precursor cells. These findings have broad implications for a variety of diseases of cognition, involving neuroinflammation and precursor cell dysfunction.
    Type: Grant
    Filed: June 21, 2006
    Date of Patent: August 16, 2011
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Michelle L. Monje, Theo D. Palmer
  • Publication number: 20040254152
    Abstract: Methods are provided for protecting an individual from adverse long-term effects of neuroinflammation. Inflammatory blockade maintains neurogenesis capability after cranial irradiation by reducing the negative effects of activated microglia on neural precursor cells. These findings have broad implications for a variety of diseases of cognition, involving neuroinflammation and precursor cell dysfunction.
    Type: Application
    Filed: April 16, 2004
    Publication date: December 16, 2004
    Inventors: Michelle L. Monje, Theo D. Palmer
  • Publication number: 20020098584
    Abstract: Disclosed are optimized methodologies for isolating and propagating stem cells from biopsies and postmortem tissues. Specifically disclosed are methods of culturing neural stem cells in the presence of a cocktail of trophic factors/co-factors for enhanced propagation.
    Type: Application
    Filed: November 6, 2001
    Publication date: July 25, 2002
    Inventors: Theo D. Palmer, Philip H. Schwartz, Philippe Taupin, Fred H. Gage
  • Patent number: 5219740
    Abstract: A process of mammalian gene therapy. Explanted fibroblasts are genetically modified by introducing a retroviral construct containing a nucleotide sequence encoding for a therapeutic substance. The genetically modified fibroblasts are implanted into a mammalian subject.
    Type: Grant
    Filed: February 13, 1987
    Date of Patent: June 15, 1993
    Assignee: Fred Hutchinson Cancer Research Center
    Inventors: A. Dusty Miller, Theo D. Palmer